Gavi Signs Agreement with Bavarian Nordic to Rapidly Secure 500,000 Doses of Mpox Vaccines for Africa
The advance purchase agreement (APA) will be funded by Gavi’s First Response Fund, a mechanism created after the COVID-1…
The advance purchase agreement (APA) will be funded by Gavi’s First Response Fund, a mechanism created after the COVID-1…
First mpox vaccine to obtain prequalification by the WHO Approval will help accelerate access to the vaccine for all…
Vaccine donations from the European Commission, the U.S. government and Bavarian Nordic are now entering the DRC, the ep…
Bavarian Nordic A/S (OMX: BAVA) announced today that Singapore’s medicines regulatory authority, Health Sciences Authori…
Interim results from clinical study show non-inferiority of immune responses from mpox/smallpox vaccination in adolescen…
Bavarian Nordic A/S (OMX: BAVA) announced today a new order from HERA (the European Health Emergency Preparedness and Re…
Bavarian Nordic A/S (OMX: BAVA) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the Eu…
Bavarian Nordic A/S (OMX: BAVA) announced today that the Swiss Agency for Therapeutic Products, Swissmedic, has approved…
The Luxembourg’s Quantum Communications Infrastructure project (LuxQCI), coordinated by the Department of Media, Telecom…
Um der Einführung nationaler Digitalsteuern entgegenzuwirken und einheitliche internationale Standards in der Steuerpoli…